about
Treatment and prevention of malaria in pregnancy and newborn.Increased fetal brain perfusion and neonatal neurobehavioral performance in normally grown fetuses.Decreased regional brain volume and cognitive impairment in preterm children at low risk.Differential cerebral and neuropsychological consequences in dizygotic twins with prenatal alcohol exposure.Differential effects of intrauterine growth restriction on brain structure and development in preterm infants: a magnetic resonance imaging study.Estimated weight centile as a predictor of perinatal outcome in small-for-gestational-age pregnancies with normal fetal and maternal Doppler indices.Proton magnetic resonance spectroscopy reveals medial temporal metabolic abnormalities in adolescents with history of preterm birth.Gestational age at preterm birth in relation to corpus callosum and general cognitive outcome in adolescents.Abnormal orbitofrontal development due to prematurity.Hippocampal functional magnetic resonance imaging during a face-name learning task in adolescents with antecedents of prematurity.Hippocampal gray matter reduction associates with memory deficits in adolescents with history of prematurity.Neurobehavioral outcomes in preterm, growth-restricted infants with and without prenatal advanced signs of brain-sparingPrevalence and perinatal outcome of dichorionic and monochorionic twins with nuchal translucency above the 99thpercentile and normal karyotypeNeurobehavior in Term, Small-for-Gestational Age Infants With Normal Placental FunctionPrediction of hyperbilirubinaemia in the healthy term newbornA different methodology for evaluating exhaled endogenous nitric oxide in newbornsFalse positives in the prenatal ultrasound screening of fetal structural anomaliesObstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose[Recommendations for the computerisation of neonatology services]
P50
Q37053822-F9A5C654-8A56-4F14-881F-081D22C1FCC1Q43870095-183AC0BC-DFC9-4608-8065-7E0C1F385AF6Q44274339-22030810-0FC4-483A-AF53-5F79EADE2FD4Q44945335-173B8F9A-0B9F-4A39-AB74-BC8B6CBA896DQ45721925-08F75CCF-56D7-46FA-A1D6-AAE3A91E0B64Q46325906-F252E6C5-BDE4-49A7-BE38-6C836B2DA148Q46505874-E4E9791B-2C3D-46FE-8D13-DC357A3961FDQ48100125-02CFC552-98F9-4C39-BEBE-9AE3BE50D8F4Q48356362-A3A8A084-AE13-4A4D-95DA-282EBE1C7DD8Q48957880-16364F8D-61A0-4DC0-A69A-C586967B61ECQ51984824-25540C19-0444-4BA9-8301-1E7F92AEF497Q57316894-12F87FA5-B999-445F-B43C-9ADDD091031CQ57316912-EC1BA54E-553D-4C69-AAFB-497754176CABQ57316915-09174C03-8155-47A8-A06E-B0E583165151Q73581257-778B997E-B48F-45A9-B360-0A6CB2B17DC6Q77794510-EAE4D6A3-CE96-4186-B14E-DC6E585C2ED7Q79415884-7F6246D8-F88B-47A5-B93F-1AD6C8E86555Q84885945-809569B2-F3B2-4B0F-8595-D38BE5B575D4Q85535817-C54373E0-D89D-4395-A86F-D875D1111F4A
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-8000-6730
@en
name
Francesc Botet
@ast
Francesc Botet
@en
Francesc Botet
@es
Francesc Botet
@nl
type
label
Francesc Botet
@ast
Francesc Botet
@en
Francesc Botet
@es
Francesc Botet
@nl
prefLabel
Francesc Botet
@ast
Francesc Botet
@en
Francesc Botet
@es
Francesc Botet
@nl
P214
P950
P106
P1153
6603049814
7004531627
P1580
P21
P214
P31
P4012
P496
0000-0002-8000-6730
P7859
viaf-87958116